Treats bacterial infections such as:
- urinary tract infections
- respiratory tract infections
- dermal infections.
Possible Side Effects:
No drug-related side effects were reported in 122 clinical cases treated with enrofloxacin injectable solution followed by enrofloxacin tablets at 5.0 mg/kg per day.
Keep out of reach of children.
Do not use in pregnant or nursing animals.
The use of this product in cats may result in Retinal Toxicity
Enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones.
Based on the studies discussed under the section on Animal Safety Summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). The safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. Large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. In clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. However, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.
Store at controlled room temperature, 68-77°F (20-25°C). Protect from direct sunlight. Do not freeze. In use shelf life: 28 days at 77°F (25°C).
It is important to follow your Veterinarian's prescription instructions for your pet.
DOSAGE AND ADMINISTRATION: Enrofloxacin Antibacterial Injectable Solution may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
Enrofloxacin Antibacterial Injectable Solution may be administered as follows:
Weight of Animal
Enrofloxacin Antibacterial Injectable Solution*
9.1 kg (20 lb)
27.2 kg (60 lb)
*The initial Enrofloxacin Antibacterial Injectable Solution administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy.
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
Each mL of injectable solution contains: enrofloxacin 22.7 mg, n-butyl alcohol 30 mg, potassium hydroxide for pH adjustment and water for injection, q.s.